ArticleHeliyon2024

Osimertinib is associated with improved outcomes in pre-treated non-small cell lung cancer leptomeningeal metastases: A systematic review and meta-analysiss.

David J H Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.